Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 3 boards, counting each seat separately. Longest: Enliven Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Immunovant Inc. September 2, 202686.0%
-
Immunovant Inc. August 27, 202594.9%
-
BridgeBio Oncology Therapeutics Inc. August 4, 2025100.0%
-
Enliven Therapeutics Inc. June 24, 202599.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 7, 2026 | Immunovant Inc. | Grant or award | +13,880 | — | — |
| May 1, 2025 | Immunovant Inc. | Grant or award | +25,016 | — | — |
| Feb 23, 2023 | Enliven Therapeutics Inc. | Grant or award | +87,372 | — | — |
Questions about Jake Bauer
What boards is Jake Bauer on?
Jake Bauer sits on the boards of BridgeBio Oncology Therapeutics Inc., Enliven Therapeutics Inc. and Immunovant Inc.
How long has Jake Bauer served on boards?
Our records show at least 7 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.